drugset / Trial / NCT00029848

Obese Patients With Type 2 Diabetes

NCT00029848

Phase 3 Completed 1045 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Timeline

Start
2001-10
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rimonabant Small molecule 5 mg
Subject Rimonabant Small molecule 20 mg